Cite
HARVARD Citation
Mazzoni, F. et al. (2018). Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences. Tumori. 104 (6), pp. NP5-NP9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mazzoni, F. et al. (2018). Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences. Tumori. 104 (6), pp. NP5-NP9. [Online].